India’s pharmaceutical sector is currently experiencing an unprecedented rise, presenting significant opportunities for aspiring business owners. Fueled by a combination of factors—including increasing healthcare spending, a growing geriatric segment, and a robust government emphasis on ‘Make in India’—the landscape is ripe for disruption